alexa Cancer Metabolomics in the Context of Systems Biology | Open Access Journals
ISSN: 2153-0769
Metabolomics:Open Access
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Cancer Metabolomics in the Context of Systems Biology

Ariel Fernández1,2,3*

1Argentine Mathematics Institute, CONICET (National Research Council), Buenos Aires 1083, Argentina

2Collegium Basilea, Institute for Advanced Study, CH 4053 Basel, Switzerland

3Ariel Fernández Consultancy, Avenida del Libertador 1092, Buenos Aires 1112, Argentina

*Corresponding Author:
Ariel Fernández
Argentine Mathematics Institute
CONICET (National Research Council)
Buenos Aires 1083, Argentina
Tel: 818 964 6624
E-mail: [email protected]

Received date: July 9, 2013; Accepted date: July 11, 2014; Published date: July 18, 2014

Citation: Fernández A (2014) Cancer Metabolomics in the Context of Systems Biology. Metabolomics 4:e127 doi: 10.4172/2153-0769.1000e127

Copyright: © 2014 Fernández A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Metabolomics:Open Access

Keywords

Cancer; Genomics; Transcriptomics; Proteomics; Interactomics; Metabolomics; Networks; Profiling; Biomarker; Fingerprinting; Personalized medicine; Integrative biology

Editorial

In spite of significant forays for gathering information at the “omics” level during the current postgenomics era, an effective integration and processing of this information to improve human medicine is still felt to be lacking. On the other hand, metabolomics aims at generating a direct chemical fingerprint of all the cellular processes taking place in a living organism. As such, it strives to provide a systematic profile of biochemical intermediates and products, and hence integrates and distills information from the genomic, transcriptomic, proteomic, fluxomic and interactomic levels.

Because metabolomics makes strides through such natural integration and distillation of omics information, it lends itself naturally to improve medicine in a manner in which systems biology approaches can prove particularly helpful. In spite of commendable preliminary efforts in this direction, a significant gap still exists between highthroughput “omics” acquisition of information and its systems-level interpretation [1].

While profiling and fingerprinting platforms furnish large-scale omics data, systems biology should in principle enable network building and dynamic integration of the information. Thus, genomic, transcriptomic and proteomic large-scale data represent valuable input data, while metabolic intermediate levels, being direct markers of cellular activity, serve as the ultimate testing ground for the systems biology models. This level of model building may ultimately lead to the identification of master regulators [2]. Yet, at a more general level, it is at this point unclear what level of omics information coarsegraining will become necessary and sufficient to enable integration and correlation of data in a manner that will enrich and empower the metabolomics output [3].

It is likely that a synergic relation between metabolomics and systems biology may ultimately trigger a revolution in personalized medicine. The diagnostic use of metabolic multiplexing readouts will become significantly more efficacious when integrated with the patient omics profile enabled or facilitated by system biology models. The synergy between metabolomics and systems biology will fundamentally transform diagnostics, disease prevention, and therapy.

Thus, visionary thinking in the field of metabolomics invites integration with functional genomics, transcriptomic and proteomics platforms enabled by network modeling. In this regard, this author genuinely concurs with the current “mantra” that technological innovation is likely to lead the way to scientific discovery. In line with this thinking, our journal Metabolomics: Open Access is expected to become a suitable venue to report novel profiling platforms and fingerprinting technologies, but also a forum that welcomes contributions that combine experimental and computational approaches, as inter-discipline cross-fertilization is the only viable way to achieve a complete understanding of cellular processes.

These efforts may prove germane to understand cancer at the molecular level. This area has been traditionally focused on transformations in signaling molecules that turn homeostatic cells into malignant ones. However, it is becoming more apparent that dynamic relational analysis of multi-dimensional omics data will be needed to gain an effective understanding of the molecular etiology of the disease. As indicated above, metabolomics remains naturally at the heart of this integration, but since it only captures end products and substrates of cellular chemical processes, the metabolomics data needs to be fleshed out at the different omics levels to fully understand its origin and implications. Much of this integration effort will be hopefully directed at (1) Assess the effect of genomic and transcriptomic aberrations on dysfunctional cell signaling architectures and (2) Investigate network aberrant re-wiring, mapping the changes of the individual proteins responsible for spatiotemporal aberrant re-design in order to better understand cancer biology at the systems level.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 11478
  • [From(publication date):
    August-2014 - Sep 20, 2017]
  • Breakdown by view type
  • HTML page views : 7721
  • PDF downloads :3757
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords